- Home
- GOSS vs RSVR Comparison
GOSS vs RSVR Comparison
Compare GOSS & RSVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOSS | RSVR |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | United States |
| Employees | 145 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.2M | 493.9M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | GOSS | RSVR |
|---|---|---|
| Price | $0.44 | $9.84 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | $4.91 | ★ $11.50 |
| AVG Volume (30 Days) | ★ 26.7M | 128.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 78.81 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $114,701,000.00 | N/A |
| Revenue This Year | N/A | $10.95 |
| Revenue Next Year | N/A | $4.13 |
| P/E Ratio | ★ N/A | $77.14 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.33 | $6.56 |
| 52 Week High | $3.87 | $10.32 |
Technical Indicators
Market Signals| Indicator | GOSS | RSVR |
|---|---|---|
| Relative Strength Index (RSI) | 22.21 | 78.21 |
| Support Level | $0.33 | $7.31 |
| Resistance Level | $0.60 | $10.32 |
| Average True Range (ATR) | 0.06 | 0.30 |
| MACD | 0.04 | 0.08 |
| Stochastic Oscillator | 45.47 | 82.04 |
Price Performance
Historical ComparisonAbout GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About RSVR Reservoir Media Inc.
Reservoir Media Inc is an independent music company. It operates a music publishing business, a recorded music business, a management business, and a rights management entity in the Middle East. The company's segments include Music Publishing and Recorded Music. It generates the maximum of its revenue from the Music Publishing segment.